glp 1 3 months on a GLP-1 Report back: 3 months off

GLP-1GLP-1GLP-1BS

The Ozempic vision loss lawsuit involves claims that semaglutide medications, including Ozempic, Wegovy, and Rybelsus, may be associated with non-arteritic...

Novo Nordisks Xultophy gets positive recommendation in Europe, full approval to hopefully come soon!

Learn all about our BCBSIL member programs, including discount programs, coverage while traveling, wellness perks and more.

An informational overview of reported February 2026 developments, FDA-approved vs

With key GLP-1 drug patents expected to expire around March 2026, Indian pharmaceutical companies are preparing to launch lower-cost alternatives in one of the fastest-growing therapeutic markets